{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T02:47:44Z","timestamp":1794365264064,"version":"4.9.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019125","name":"National Institute of Pharmaceutical Education and Research Ahmedabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.drudis.2025.104387","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:05:53Z","timestamp":1748261153000},"page":"104387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Navigating the complexities of spinal cord injury: an overview of pathology, treatment strategies and clinical trials"],"prefix":"10.1016","volume":"30","author":[{"given":"Manjeet","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104387_b0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s10195-021-00623-6","article-title":"The role of electrical stimulation for rehabilitation and regeneration after spinal cord injury","volume":"23","author":"Karamian","year":"2022","journal-title":"J Orthop Traumatol"},{"key":"10.1016\/j.drudis.2025.104387_b0010","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1039\/D0TB02740E","article-title":"Nanopharmaceutical-based regenerative medicine: a promising therapeutic strategy for spinal cord injury","volume":"9","author":"Zhao","year":"2021","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.drudis.2025.104387_b0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/ten.teb.2020.0188","article-title":"Nanotechnology for the treatment of spinal cord injury","volume":"27","author":"Zimmermann","year":"2021","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.drudis.2025.104387_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.18","article-title":"Traumatic spinal cord injury","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.drudis.2025.104387_b0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/1673-5374.317961","article-title":"Delving into the recent advancements of spinal cord injury treatment: a review of recent progress","volume":"17","author":"Flack","year":"2022","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.drudis.2025.104387_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.00282","article-title":"Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.drudis.2025.104387_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2019.00490","article-title":"Delayed azithromycin treatment improves recovery after mouse spinal cord injury","volume":"13","author":"Kopper","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.drudis.2025.104387_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112529","article-title":"Advanced approaches to regenerate spinal cord injury: the development of cell and tissue engineering therapy and combinational treatments","volume":"146","author":"Saremi","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2025.104387_b0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00441-019-03039-1","article-title":"Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications","volume":"377","author":"Venkatesh","year":"2019","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.drudis.2025.104387_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4055\/cios.2017.9.1.1","article-title":"Spinal cord injury and related clinical trials","volume":"9","author":"Kim","year":"2017","journal-title":"Clin Orthop Surg"},{"key":"10.1016\/j.drudis.2025.104387_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10081872","article-title":"Spinal cord repair: from cells and tissue engineering to extracellular vesicles","volume":"10","author":"Guo","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104387_b0060","first-page":"463","article-title":"Drug repurposing for spinal cord injury: progress towards therapeutic intervention for primary factors and secondary complications","volume":"37","author":"Guha","year":"2023","journal-title":"Pharmaceut Med"},{"key":"10.1016\/j.drudis.2025.104387_b0065","article-title":"Maresin-1 prevents blood-spinal cord barrier disruption associated with TRPV4 elevation in the experimental model of spinal cord injury","volume":"1868","author":"Pathak","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.drudis.2025.104387_b0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.14245\/ns.2244976.488","article-title":"Different ways to die: cell death pathways and their association with spinal cord injury","volume":"20","author":"Guha","year":"2023","journal-title":"Neurospine"},{"key":"10.1016\/j.drudis.2025.104387_b0075","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.4103\/1673-5374.194710","article-title":"Anti-inflammatory properties of the glial scar","volume":"11","author":"Gesteira","year":"2016","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.drudis.2025.104387_b0080","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12264-013-1358-3","article-title":"The glial scar in spinal cord injury and repair","volume":"29","author":"Yuan","year":"2013","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.drudis.2025.104387_b0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12035-012-8287-4","article-title":"Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects","volume":"46","author":"Karimi-Abdolrezaee","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.drudis.2025.104387_b0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ncl.2021.02.004","article-title":"Acute traumatic spinal cord injury","volume":"39","author":"Eli","year":"2021","journal-title":"Neurol Clin"},{"key":"10.1016\/j.drudis.2025.104387_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2018.9.SPINE18682","article-title":"Time is spine: a review of translational advances in spinal cord injury","volume":"30","author":"Badhiwala","year":"2019","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.drudis.2025.104387_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032037","article-title":"Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS)","volume":"7","author":"Fehlings","year":"2012","journal-title":"PLoS One"},{"issue":"suppl. 3","key":"10.1016\/j.drudis.2025.104387_b0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/21925682231189928","article-title":"AO spine\/praxis clinical practice guidelines for the management of acute spinal cord injury: an introduction to a focus issue","volume":"14","author":"Kwon","year":"2024","journal-title":"Global Spine J"},{"key":"10.1016\/j.drudis.2025.104387_b0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11910-019-0984-1","article-title":"Modern medical management of spinal cord injury","volume":"19","author":"Karsy","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.drudis.2025.104387_b0115","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s00586-008-0729-3","article-title":"Role of electrical stimulation for rehabilitation and regeneration after spinal cord injury: an overview","volume":"17","author":"Hamid","year":"2008","journal-title":"Eur Spine J"},{"key":"10.1016\/j.drudis.2025.104387_b0120","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-025-08077-y","article-title":"Efficacy of neuromodulation and rehabilitation approaches on pain relief in patients with spinal cord injury: a systematic review and meta-analysis","author":"Portaro","year":"2025","journal-title":"Neurol Sci"},{"key":"10.1016\/j.drudis.2025.104387_b0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41393-020-00610-4","article-title":"Physiotherapy interventions for the treatment of spasticity in people with spinal cord injury: a systematic review","volume":"59","author":"Barbosa","year":"2021","journal-title":"Spinal Cord"},{"key":"10.1016\/j.drudis.2025.104387_b0130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000510775","article-title":"Trends in clinical trials for spinal cord stimulation","volume":"99","author":"Harmsen","year":"2021","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.drudis.2025.104387_b0135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41586-020-03180-w","article-title":"Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury","volume":"590","author":"Squair","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104387_b0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41586-023-06094-5","article-title":"Walking naturally after spinal cord injury using a brain\u2013spine interface","volume":"618","author":"Lorach","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2025.104387_b0145","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1109\/TNSRE.2021.3090269","article-title":"Brain-computer-spinal interface restores upper limb function after spinal cord injury","volume":"29","author":"Samejima","year":"2021","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"10.1016\/j.drudis.2025.104387_b0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuroscience.2014.01.059","article-title":"Riluzole improves outcome following ischemia-reperfusion injury to the spinal cord by preventing delayed paraplegia","volume":"265","author":"Wu","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.drudis.2025.104387_b0155","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/brain\/awg178","article-title":"Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice","volume":"126","author":"Wells","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2025.104387_b0160","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/089771503770195867","article-title":"Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat","volume":"20","author":"Lee","year":"2003","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.drudis.2025.104387_b0165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5607\/en21030","article-title":"Alendronate enhances functional recovery after spinal cord injury","volume":"31","author":"Choi","year":"2022","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.drudis.2025.104387_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.wneu.2021.02.116","article-title":"Updated review: the steroid controversy for management of spinal cord injury","volume":"150","author":"Canseco","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.drudis.2025.104387_b0175","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3171\/jns.1985.63.5.0704","article-title":"Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study","volume":"63","author":"Bracken","year":"1985","journal-title":"J Neurosurg"},{"key":"10.1016\/j.drudis.2025.104387_b0180","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199005173222001","article-title":"A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study","volume":"322","author":"Bracken","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2025.104387_b0185","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jama.1997.03540440031029","article-title":"Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury","volume":"277","author":"Bracken","year":"1997","journal-title":"JAMA"},{"issue":"suppl. 3","key":"10.1016\/j.drudis.2025.104387_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/2192568217701910","article-title":"A clinical practice guideline for the management of patients with acute spinal cord injury: recommendations on the type and timing of rehabilitation","volume":"7","author":"Fehlings","year":"2017","journal-title":"Global Spine J"},{"issue":"suppl. 4","key":"10.1016\/j.drudis.2025.104387_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/NEU.0000000000000953","article-title":"The aging of the global population: the changing epidemiology of disease and spinal disorders","volume":"77","author":"Fehlings","year":"2015","journal-title":"Neurosurgery"},{"key":"10.1016\/j.drudis.2025.104387_b0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12951-025-03153-z","article-title":"Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatment of spinal cord injury","volume":"23","author":"Dong","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.drudis.2025.104387_b0205","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1089\/neu.2023.0163","article-title":"Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): a multi-center, randomized, placebo-controlled, double-blinded trial","volume":"40","author":"Fehlings","year":"2023","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.drudis.2025.104387_b0210","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.apmr.2024.02.049","article-title":"NVG-291 Phase 1 results and Phase 1b\/2a study design in individuals with spinal cord injury","volume":"105","author":"Mikol","year":"2024","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.drudis.2025.104387_b0215","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.expneurol.2018.08.003","article-title":"Recovery after spinal cord injury by modulation of the proteoglycan receptor PTP\u03c3","volume":"309","author":"Rink","year":"2018","journal-title":"Exp Neurol"},{"key":"10.1016\/j.drudis.2025.104387_b0220","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1038\/s41467-018-06505-6","article-title":"Modulation of proteoglycan receptor PTP\u03c3 enhances MMP-2 activity to promote recovery from multiple sclerosis","volume":"9","author":"Luo","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104387_b0225","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s10439-019-02198-0","article-title":"Automated gait analysis detects improvements after intracellular \u03c3 peptide administration in a rat hemisection model of spinal cord injury","volume":"47","author":"Ham","year":"2019","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.drudis.2025.104387_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.614949","article-title":"Negative impact of Sigma-1 receptor agonist treatment on tissue integrity and motor function following spinal cord injury","volume":"12","author":"Lattard","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2025.104387_b0235","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3267352","article-title":"A look into stem cell therapy: exploring the options for treatment of ischemic stroke","volume":"2017","author":"Reis","year":"2017","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.drudis.2025.104387_b0240","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/j.biomaterials.2010.12.032","article-title":"Homing of endogenous stem\/progenitor cells for in situ tissue regeneration: promises, strategies, and translational perspectives","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2025.104387_b0245","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1080\/14712598.2021.1914582","article-title":"Regenerative replacement of neural cells for treatment of spinal cord injury","volume":"21","author":"McIntyre","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.drudis.2025.104387_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052579","article-title":"Optimal preclinical conditions for using adult human multipotent neural cells in the treatment of spinal cord injury","volume":"22","author":"Won","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104387_b0255","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/cr.2012.171","article-title":"Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells","volume":"23","author":"Nakamura","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2025.104387_b0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.conb.2014.03.010","article-title":"Axonal growth and connectivity from neural stem cell grafts in models of spinal cord injury","volume":"27","author":"Lu","year":"2014","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.drudis.2025.104387_b0265","doi-asserted-by":"crossref","first-page":"914","DOI":"10.5966\/sctm.2015-0381","article-title":"Concise review: bridging the gap: novel neuroregenerative and neuroprotective strategies in spinal cord injury","volume":"5","author":"Ahuja","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.drudis.2025.104387_b0270","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1152\/physrev.00017.2017","article-title":"The biology of regeneration failure and success after spinal cord injury","volume":"98","author":"Tran","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.drudis.2025.104387_b0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/stem.2926","article-title":"Concise review: laying the groundwork for a first-in-human study of an induced pluripotent stem cell-based intervention for spinal cord injury","volume":"37","author":"Tsuji","year":"2019","journal-title":"Stem Cells"},{"key":"10.1016\/j.drudis.2025.104387_b0280","article-title":"Long-term clinical and safety outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic thoracic spinal cord injury","volume":"5","author":"Martin","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.drudis.2025.104387_b0285","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/cells11040685","article-title":"Regenerative rehabilitation and stem cell therapy targeting chronic spinal cord injury: a review of preclinical studies","volume":"11","author":"Tashiro","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104387_b0290","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4103\/1673-5374.274347","article-title":"Human umbilical cord mesenchymal stem cells to treat spinal cord injury in the early chronic phase: study protocol for a prospective, multicenter, randomized, placebo-controlled, single-blinded clinical trial","volume":"15","author":"Yang","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.drudis.2025.104387_b0295","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s13311-013-0178-5","article-title":"Neuroprotection and axonal regeneration after lumbar ventral root avulsion by re-implantation and mesenchymal stem cells transplant combined therapy","volume":"10","author":"Torres-Esp\u00edn","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.drudis.2025.104387_b0300","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.brainres.2016.04.025","article-title":"Preconditioning in lowered oxygen enhances the therapeutic potential of human umbilical mesenchymal stem cells in a rat model of spinal cord injury","volume":"1642","author":"Zhilai","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.drudis.2025.104387_b0305","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopha.2017.04.126","article-title":"Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury","volume":"91","author":"Shende","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2025.104387_b0310","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcyt.2020.08.008","article-title":"Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study","volume":"23","author":"Albu","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.drudis.2025.104387_b0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41427-023-00526-4","article-title":"Biomaterial-based regenerative therapeutic strategies for spinal cord injury","volume":"16","author":"Chen","year":"2024","journal-title":"NPG Asia Mater"},{"key":"10.1016\/j.drudis.2025.104387_b0320","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41591-018-0296-z","article-title":"Biomimetic 3D-printed scaffolds for spinal cord injury repair","volume":"25","author":"Koffler","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2025.104387_b0325","first-page":"1","article-title":"Exosomes-loaded electroconductive hydrogel synergistically promotes tissue repair after spinal cord injury via immunoregulation and enhancement of myelinated axon growth","volume":"2105586","author":"Fan","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.drudis.2025.104387_b0330","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(24)00447-2","article-title":"Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial","volume":"24","author":"Weidner","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.drudis.2025.104387_b0335","unstructured":"Borana R. Clinical trials in India: deaths, side-effects and compensation. Science, The Wire. https:\/\/science.thewire.in\/health\/india-clinical-trials-deaths-side-effects-compensation-ctri-cdsco\/."},{"key":"10.1016\/j.drudis.2025.104387_b0340","unstructured":"Jayakumar PB. India now prime destination for big pharma\u2019s global clinical trials. Fortune India. https:\/\/www.fortuneindia.com\/enterprise\/india-now-prime-destination-for-big-pharmas-global-clinical-trials\/107141."},{"key":"10.1016\/j.drudis.2025.104387_b0345","first-page":"241","article-title":"Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I\/II clinical safety and primary efficacy data","volume":"7","author":"Kumar","year":"2009","journal-title":"Exp Clin Transplant"},{"issue":"suppl. 1","key":"10.1016\/j.drudis.2025.104387_b0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3727\/096368912X633798","article-title":"Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life","volume":"21","author":"Sharma","year":"2012","journal-title":"Cell Transplant"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462500100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462500100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T19:38:58Z","timestamp":1762371538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964462500100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S135964462500100X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104387","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the complexities of spinal cord injury: an overview of pathology, treatment strategies and clinical trials","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104387"}}